Analytical Data
-
Gene name
ACBD5
- Application
-
Alternative Names
Acbd5; ACBD5_HUMAN; Acyl CoA binding domain containing 5; Acyl CoA binding domain containing protein 5; Acyl Coenzyme A binding domain containing 5; Acyl-CoA-binding domain-containing protein 5; DKFZp434A2417; Endozepine related protein; KIAA1996; Membrane associated diazepam binding inhibitor; OTTHUMP00000019362; OTTHUMP00000019363; OTTHUMP00000019364; OTTHUMP00000019365; RP11-85G18.5
-
Species
Human
-
Source
E. coli
-
Tag
N- His-SUMO
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q5T8D3
-
Expression Region
1-461aa
-
Molecular Weight
67.5 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ACBD5, or Acyl-CoA Binding Domain Containing 5, is a protein known to play a crucial role in lipid metabolism and cellular signaling pathways. Research into ACBD5 has gained traction due to its potential implications in various metabolic disorders, including obesity and type 2 diabetes. This protein is believed to facilitate the transport and metabolism of fatty acids by interacting with acyl-CoA derivatives, thereby influencing lipid homeostasis within cells. Furthermore, ACBD5 is implicated in autophagy processes, which are essential for cellular maintenance and energy balance. Understanding the structure-function relationship of ACBD5 at the molecular level is vital for unraveling its contributions to metabolic regulation and identifying novel therapeutic targets for metabolic diseases. Recent advances in recombinant protein technology have enabled the generation of functional ACBD5 proteins for detailed biochemical analysis, opening new avenues for therapeutic exploration. Ongoing research focuses on characterizing the protein's binding affinities, signal transduction mechanisms, and interactions with other metabolic regulators, potentially leading to innovative strategies for managing metabolic disorders associated with dysregulated lipid metabolism.
